Entity Details

Primary name ADRO_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP22570
EntryNameADRO_HUMAN
FullNameNADPH:adrenodoxin oxidoreductase, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length491
SequenceStatuscomplete
DateCreated1991-08-01
DateModified2021-06-02

Ontological Relatives

GenesFDXR

GO terms

Show/Hide Table
GOName
GO:0004324 ferredoxin-NADP+ reductase activity
GO:0005739 mitochondrion
GO:0005743 mitochondrial inner membrane
GO:0005759 mitochondrial matrix
GO:0006091 generation of precursor metabolites and energy
GO:0006124 ferredoxin metabolic process
GO:0006694 steroid biosynthetic process
GO:0006700 C21-steroid hormone biosynthetic process
GO:0006744 ubiquinone biosynthetic process
GO:0008203 cholesterol metabolic process
GO:0015039 NADPH-adrenodoxin reductase activity
GO:0016125 sterol metabolic process
GO:0016491 oxidoreductase activity

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR021163 Ferredoxin-NADP+ reductase, adrenodoxin-typeFamilyFamily
IPR023753 FAD/NAD(P)-binding domainDomainDomain
IPR036188 FAD/NAD(P)-binding domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617717 OMIMAuditory neuropathy and optic atrophy (ANOA)An autosomal recessive disease characterized by hearing loss, visual impairment and optic atrophy, with onset in the first or second decades of life. Optic atrophy is caused by degeneration of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB03147 Flavin adenine dinucleotideDrugbanksmall molecule
DB03461 Nicotinamide adenine dinucleotide phosphateDrugbanksmall molecule